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Abstract
Reduced intercellular communication via gap junctions is correlated with carcinogenesis. Gap
junctional intercellular communication (GJIC), between normal human endometrial epithelial cells
is enhanced when endometrial stromal cells were present in culture. This enhancement of GJIC
between normal epithelial cells also occurs when they are cultured in medium conditioned by
stromal cells. This observation indicated that a soluble compound (or compounds) produced and
secreted by stromal cells mediates GJIC in epithelial cells. Previous studies have shown that
endometrial stromal cells release prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α) under
physiological conditions. When we evaluated the response of normal endometrial epithelial cells
to various concentrations of PGE2, we found enhanced GJIC with 1 nM PGE2. This is a smaller
increase in GJIC than that induced by medium conditioned by stromal cells. When the
extracellular concentration of PGE2 was measured after incubation with stromal cells, it was found
to be similar to the concentrations showing maximal GJIC between the normal epithelial cells.
When indomethecin was used to inhibit prostaglandin synthesis by stromal cells, GJIC was
reduced but not eliminated between normal endometrial epithelial cells. These observations
suggest that although PGE2 secreted by stromal cells is an important mediator of GJIC between
the epithelial cells, it is not the sole mediator. Transformed endometrial epithelial cells did not
demonstrate GJIC even in the presence of stromal cells. However, we were able to re-establish
GJIC in transformed epithelial cells when we added PGE2 to the cells. Our findings show that
PGE2 may serve as an intercellular mediator between stromal and epithelial cells that regulates
GJIC in normal and malignant epithelial cells. This suggests that maintenance of GJIC by
preserving or replacing PGE2 secretion by endometrial stromal cells may have the potential to
suppress carcinogenesis in endometrial epithelial cells.
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Introduction
With about 47,000 new cases per year, endometrial carcinoma is the invasive cancer of the
female genital tract with the highest incidence in women in the United States (American
Cancer Society, 2012). Even though these cancers are commonly detected early in their
natural history and therapeutic measures effectively treat, and even cure, a large fraction of
these cancers, still about 8,000 American women die of this disease each year (American
Cancer Society, 2012). While the incidence and death rate from endometrial cancer varies
over time the approximate proportion of women succumbing to this disease has not changed
greatly. This continuing toll of endometrial cancer deaths despite the current armamentarium
of surgical, radiologic and chemotherapeutic treatments points out the need for further
investigations of endometrial cancer that may reveal new therapeutic options. We recognize
that estrogen exposure not counteracted by progesterone is the primary etiologic risk factor
for developing this disease but we do not know conclusively the mechanism of pathogenesis
by which endometrial cancer is caused by estrogen.
One of the hallmarks of endometrial cancer that is used as one of the criteria for its diagnosis
is the relationship between endometrial glands and the intervening stroma. In the normal
endometrium endometrial glands are separated by ample quantities of loose stroma
predominantly populated by endometrial stromal cells. The transition to endometrial cancer
is typically accompanied by the loss of most of the stroma between glands yielding back-to-
back apposition of malignant glands. The common type of endometrial cancer is preceded
by a form of hyperplasia thought to have a high risk of progression to cancer (“Endometrial
Intraepithelial Neoplasia” (EIN)), and this reduction of stroma also is seen at this stage of
the natural history of endometrial cancer (Mazur, 2005). An objective analysis of
endometrial hyperplasias by computerized imaging techniques distinguished EIN, based
largely on reduction of stromal cells between glands. Diagnosis of EIN by morphometric
criteria proved to be a better predictor of progression to cancer than traditional
classifications of hyperplasia (Baak, et al., 2005). The decreased proportion of stromal cells
between glands in EIN suggests that mechanisms regulating homeostatic stromal-epithelial
cell interactions are defective in endometrial cancer and its pre-invasive precursor.
Over a number of years our laboratory has studied the regulation of homeostatic stromal-
epithelial cell interactions in human endometrium using human endometrial stromal and
epithelial cells in co-cultures. We showed that endometrial epithelial cells grown on
“Matrigel” would generate well-formed glands with polarized cells and a central lumen
(Rinehart, et al., 1988). When colonies of stromal and epithelial cells were co-cultured on
Matrigel and grew to contact each other they formed a basement membrane-like structure,
with dense extracellular fibrillar protein networks and hemi-desmosomes at the basal surface
of epithelial cells at the interface (Hopfer et al., 1994). Stromal cells embedded in Matrigel
reduce the proliferation of epithelial cells as measured by 3H-thymidine uptake, cell
counting, and labeling of DNA with BrdU in situ (Arnold et al., 2001). This inhibitory effect
is not observed when the stromal cells are grown on plastic, suggesting that the interaction
between stromal cells and Matrigel influences paracrine factors produced by stromal cells.
When normal human foreskin fibroblasts (NHF-1 cells) or medium conditioned by them
were used in place of endometrial stromal cells in parallel studies they had no influence on
endometrial epithelial cell growth. This eliminates the possibility that these results were due
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to depletion of the medium by the stromal or NHF-1 cells or that these effects were not
specific to endometrial stromal cells.
This co-culture system has been validated further by demonstrating the ability of epithelial
cells to respond to hormonal stimulation. In endometrial tissue reconstructed in this manner,
appropriate hormonal responses to estrogen and progesterone regulating epithelial cell
proliferation and differentiation of these cells depends on the presence of stromal cells
together with epithelial cells (Arnold et al., 2001). In the presence of progesterone, normal
endometrial epithelial cells were shown to increase their secretion of glycodelin when co-
cultured with stromal cells. We found that stromal cells mediate the proliferative effect of
estrogens (or anti-proliferative effect of progestins) on endometrial epithelial cells by their
secretion of paracrine growth factors. This interaction could be reproduced with medium
conditioned by stromal cells in place of direct co-culture. Moreover, we found that only
stromal cells grown on extracellular matrix (ECM) could mediate the estrogen regulation of
epithelial cell proliferation (Arnold et al., 2002). The studies using conditioned medium
point out the role of paracrine growth factors secreted by stromal cells as regulators of
epithelial cell proliferation.
We subsequently immortalized a primary stromal cell population by transducing a human
telomerase reverse transcriptase subunit (hTERT) (Barbier et al., 2005). This cell line,
named SHT290, has been shown to substitute for normal primary stromal cells in the co-
culture system, and can mediate the hormonally regulated proliferative response in the same
manner. We used this system to recreate the progestagenic effects of the hormone
replacement therapy drug Tibolone in endometrium in vivo, and showed that it results from
the metabolism of the drug by co-cultures of endometrial cells (Barbier et al., 2008). This
pattern of metabolism is not demonstrated by epithelial cells cultured in the absence of
stromal cells; Tibolone was also estrogenic in mono-cultures. This is further evidence that
endometrium reconstructed in these co-cultures reproduces the normal endometrium in vivo
better than endometrial mono-cultures.
Another aspect of endometrial epithelial-stromal interaction that we studied is gap junctions,
the semi-permeable transmembrane pores formed between adjacent cells that permit the
exchange of molecules smaller than one kilodalton (KDa) [Larsen and Risinger, 1985;
Spray, 1985; Revel et al., 1985]. Gap junctions are formed by hemichannels composed of
six protein subunits referred to as connexins in both adjacent cells which align and assemble
into a channel between the cells called a connexon [Beyer, 1990]. This aspect of cell
interaction is important because several groups of investigators have shown a correlation
between reduced functioning of gap junctions, known as gap junctional intercellular
communication (GJIC), and carcinogenesis and metastatic potential, primarily in cells of
epithelial origin [Cronier, L., et al., 2009; Fitzgerald et al., 1994; Klann et al., 1989; Leithe,
et al., 2006; Mesnil, et al., 2005; Nicholson et al., 1988; Trosko, 2003; Vinken, et al., 2009;].
Consistent with this, our earlier studies on gap junctions showed an inverse correlation
between connexin 43 (Cx 43) protein expression in endometrial cells and the degree of
progression in grade of endometrial epithelial carcinoma in vitro and in vivo [Schlemmer et
al., 1999]. Conversely, studies with normal endometrial epithelial cells showed that co-
culture with normal endometrial stromal cells increases Cx 43 expression in the epithelial
cells. Subsequent studies showed that GJIC was induced in normal epithelial cells when they
were co-cultured with stromal cells; this effect could not be reproduced when malignant
epithelial cells were cultured with stromal cells [Schlemmer and Kaufman, 2000].
Furthermore, ultrastructural studies showed that interactions between stromal and epithelial
cells in the normal human endometrium caused an increase in the size and number of gap
junctions in epithelial cells [Roberts et al., 1988].
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In this report we consider how human endometrial stromal cells mediate their effects on
GJIC between endometrial epithelial cells and whether this effect could be mediated by
medium conditioned by stromal cells. Further, based on reports that exogenous application
of prostaglandin E1 [Radu et al., 1982] increased GJIC between mammalian cells we
evaluated whether prostaglandins could replace stromal cells or stromal cell-conditioned
medium on GJIC in endometrial epithelial cells and whether prostaglandins could influence
GJIC between endometrial cancer cells.
Material and Methods
Materials
Indomethecin and prostaglandins E1, E2, and F2α were purchased from Sigma-Aldrich (St.
Louis, MO).
Endometrial Tissue Isolation
Samples of uterine tissue were obtained from patients at the University of North Carolina
Hospitals. Fragments of endometrial tissue are collected and placed in ice cold F12 media
with antibiotics, minced into 1 mm pieces, and enzymatically digested with collagenase I
and III (Sigma-Aldrich., St. Louis, MO) overnight at 4°C. Endometrial epithelial and
stromal cells were separated by differential centrifugation at 4°C using 1000g for 3 min to
isolate epithelial cells and 2500g for 5 min to isolate stromal cells.
Tissue Culture
Endometrial epithelial cell lines used for these studies were FEEC (Fetal Endometrial
Epithelial Cells; immortalized with SV40 large T antigen), HEC-1A (Stage 1A endometrial
carcinoma, [Kuramoto et al., 1972]), and RL-95-2 (Grade II endometrial carcinoma, [Way et
al., 1983]). Normal endometrial stromal cells were obtained as described above and grown
from frozen stocks maintained in our laboratory. Endometrial epithelial and stromal cells
were cultured on 100 mm plastic dishes (Thermo Fisher Scientific, Pittsburgh, PA) coated
with a 1:5 dilution of phenol-red free Matrigel (Collaborative Biomedical Products Division,
BD Biosciences Discovery, Bedford, MA). The growth medium consisted of phenol-red free
M199/F12 (1:1) with 2 μg/ml insulin. Antibiotic/antimycotic (Life Technologies, Gibco
BRL Division, Gaithersburg, MD), Mitoplus (Collaborative Biomedical Products, Bedford,
MA), bovine pituitary extract (Collaborative Biomedical Products, Bedford, MA), and
insulin-transferrin-selenium (Boehringer-Mannheim, Indianapolis, IN) were added
according to manufacturers’ instructions. Phenol red was omitted to help reduce potential
effects of estrogen agonists [Bindal et al., 1988]. The FEEC, HEC-1A, and RL-95-2 cell
lines were chosen to represent progressive stages in the evolution of endometrial cancer.
Cells were harvested while cultures were in exponential growth phase by removal of growth
medium and treatment of cells with 2 ml of Dispase (Collaborative Biomedical Products,
Bedford, MA) per 100 mm plastic dish for 10 min at 37°C. Subsequently the cells were
washed with HBSS containing 10 mM EDTA, washed again with HBSS, and then replanted
on single- well LAB-TEK glass microscope slides (NUNC Division, Thermo Fisher
Scientific, Pittsburgh, PA) that had been coated with a 1:5 dilution of phenol-red free
Matrigel for microinjection experiments.
Microinjection
This procedure was performed in a manner similar to Ruch and Klaunig with minor
modifications [Ruch and Klaunig, 1988]. Glass micropipettes were made with a Model P-87
micropipette puller (Sutter Instrument Co., Novato, CA) and backfilled with 5% (w/v)
Lucifer Yellow CH (Sigma-Aldrich Co., St. Louis, MO) in 0.1 M LiCl. Microinjections
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were performed on exponentially growing cells using a Model 5242 air pressure
microinjector (Eppendorf North America Inc., Hauppauge, N.Y.) under differential
interference contrast (DIC) microscopy. Photographs were taken of epifluorescent light
generated from the donor and dye coupled cells 5 min after microinjection using a Zeiss
Inverted Microscope (Carl Zeiss Co., USA, Peabody, MA). For co-cultured epithelial and
stromal cells, the donor and recipient cells were distinguished from each other as described
previously [Schlemmer and Kaufman, 2000].
Statistical Methods
The student’s t-test was used to compare results from the microinjection experiments.
PGE2 ELISA
An ELISA analysis for PGE2 was performed with a PGE2 immunoassay kit (R&D Systems
Inc., Minneapolis, MN) according to manufacturer’s directions.
Results
Figure 1 illustrates results of dye transfer experiments. Panels 1A and 1B illustrate cultures
of normal epithelial cells, cultured alone in conventional medium. Panels 1C and 1D
illustrate epithelial cells that were cultured using medium that was conditioned by stromal
cells. Conditioning of medium was done by culturing young stromal cells in the medium for
48 hours, and then diluting it 1:1 with unconditioned medium. Panels 1E and 1F illustrate
epithelial cells that were cultured in the presence of stromal cells. The photos on the left side
(panels 1A, 1C, and 1E) were taken using differential interference contrast microscopy to
identify the location of the cells analyzed, and photos on the right side (panels 1A, 1C, and
1E) were taken using epifluorescence to demonstrate cells containing Lucifer yellow. When
epithelial cells were cultured alone, dye did not spread to adjacent cells, which indicates a
lack of GJIC, (panel 1B). In contrast, there was clear evidence of dye spreading to adjacent
cells when the epithelial cells are exposed to media conditioned by stromal cells (panel 1D)
or co-cultured with stromal cells (panel 1F). Panels 1A, 1B, 1E, and 1F were previously
published [9], and are shown here only for the purpose of comparison to panels 1C and 1D.
The number of cells showing dye transfer was determined for replicate experiments and the
results were used as a measurement of GJIC capacity under the given experimental
conditions (Table 1). These results indicate that GJIC between endometrial epithelial cells is
induced by endometrial stromal cells, but the stromal cells do not have to be physically
present to exert their effect on GJIC between the epithelial cells. This indicates that
induction of GJIC in endometrial epithelial cells is mediated by one or more diffusible
extracellular factors secreted by stromal cells. Data in Table 1 showing GJIC between
epithelial cells cultured alone and with stromal cells was previously published [Schlemmer
and Kaufman, 2000] and is reprinted here for the purpose of comparison with new findings.
Because prostaglandins are known to be secreted by endometrial cells and because they
were known to increase GJIC between epithelial cells in other tissues, we evaluated certain
aspects of prostaglandin metabolism in these endometrial cell cultures. To determine
whether stromal cell cultures secreted PGE2 into the culture medium, we performed a
competitive ELISA using growth medium recovered after incubation with near-confluent
stromal cells for 48 hours. The results showed a PGE2 concentration of 182±23 ρM. Next,
we attempted to determine whether addition of PGE2 to culture medium could substitute for
stromal cells or stromal cell conditioned medium as an inducer of GJIC in endometrial
epithelial cells. Normal epithelial cells were cultured for 24 hours in growth medium to
which 1 μM, 1 nM, or 1 ρM PGE2 had been added and then GJIC was assayed. As
compared with epithelial cells cultured alone without PGE2, GJIC was inhibited by 1 μM
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PGE2, stimulated by 1 nM PGE2, and not changed significantly by 1 ρM PGE2 (Figure 2).
The results for GJIC in epithelial cells in coculture with stromal cells are shown for purposes
of comparison, and are the same as epithelial cells exposed to medium conditioned by
stromal cells. Further evidence for the involvement of PGE2 in controlling GJIC between
normal epithelial cells and stromal cells was demonstrated by pre-treatment of a coculture of
normal epithelial cells and stromal cells with 1 μM of indomethecin 24 hours before
microinjection. These experiments showed there was 85.5% inhibition of GJIC as compared
to epithelial cells cultured alone (Figure 2).
Figure 3 illustrates dye transfer following microinjection as an indication of GJIC in
transformed endometrial epithelial cells. Results show GJIC where transformed epithelial
cells were cultured without PGE2 (panels 3a, 3c, and 3e) or with the concentrations of PGE2
shown to produce the maximal GJIC effect in each of the transformed epithelial cell lines
PGE2 (panels 3b, 3d, and 3f). All of the photos were taken under epifluorescent illumination
five minutes after microinjection. FEEC cells cultured alone failed to transfer dye between
cells (panel 3a) while after treatment with 10 μM PGE2 the injected FEEC cell transferred
dye to four cells (panel 3b). HEC-1A cells cultured without PGE2 did not show GJIC (panel
3c) but after treatment with 100 nM PGE2 the injected HEC-1A cell transferred dye to four
cells (panel 3d). Similarly, untreated RL-95-2 cells did not transfer dye (panel 3e) whereas
RL-95-2 cells treated with 100 nM PGE2 transferred dye to four adjacent cells (panel 3f).
These inductive effects of PGE2 on GJIC in FEEC, HEC-1A, and RL-95-2 cells were
specific in so far as treatments with 1μM PGE1 or 1μM PGF2α did not re-establish GJIC
(data not shown).
The results of studies comparing the concentration of PGE2 to the induced effect on GJIC in
transformed endometrial epithelial cells are illustrated in Figure 4. These studies assess the
GJIC induced in response to one-log increments in concentration of PGE2 when added to
cultures of FEEC, HEC-1A, and RL-95-2 cells. Results were compared to control
experiments without PGE2. All observations showed increases in GJIC that were statistically
significant except at 10 μM PGE2 with the HEC-1A cells where the increase did not achieve
statistical significance. The results show that GJIC can be induced in each of the three cell
lines by treatments with PGE2. The maximal induction of GJIC between HEC-1A cells and
between RL-95-2 cells was observed with 0.1 μM PGE2, while it required 10 μM PGE2 to
achieve the maximal induction of GJIC in FEEC cells.
Discussion
Previous investigations have shown that intercellular communications through gap junctions
is decreased in malignancies (Cronier, L., et al., 2009; Leithe, et al., 2006; Mesnil, et al.,
2005; Vinken, et al., 2009; Yamasaki, et al., 1995). In previous studies we have
demonstrated an abnormality of connexin expression in endometrial cancers (Schlemmer, et
al., 1999). We followed this by demonstrating that intercellular communication via gap
junctions was absent in endometrial epithelial cells or endometrial cancer cells when
assessed in cell culture (Schlemmer and Kaufman, 2000). We showed, however, that co-
culture of the normal epithelial cells with stromal cells would restore intercellular
communication between the endometrial epithelial cells. Therefore, interaction between
stromal and epithelial cells was essential for this normal epithelial cell function. The results
of this study extend our previous observations concerning the activity of GJIC in human
endometrial epithelial cells. The current study shows that the stromal cells need not be
physically present for GJIC to be induced. Medium in which normal endometrial stromal
cells had been grown (conditioned medium) was able to substitute for stromal cells in
causing an increase GJIC between normal epithelial cells. The induction appears to be
mediated by one or more soluble and diffusible factors made by the stromal cells and
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secreted into their culture medium in vitro and presumably into their immediate environment
in vivo. Our studies in vitro also indicate that PGE2 is one such mediator. We have shown
that the stromal cells secrete PGE2 into the conditioned medium that can induce GJIC. We
also have shown that treatment of cultures of normal endometrial epithelial cells with 1 nM
PGE2 can induce GJIC. Conversely, we have shown that if PGE2 production is inhibited in
cultures containing stromal cells, GJIC is blocked in the epithelial cells. While treatment of
normal endometrial epithelial cell cultures with 1 nanomolar (nM) PGE2 can induce GJIC,
treatments with much higher (1 micromolar (μM)) or much lower (1 picomolar (ρM))
concentrations of PGE2 inhibited GJIC or had no effect. Even at its most effective
concentration, treatment of epithelial cell cultures with PGE2 restored only part of the
induction of GJIC produced by stromal cells. This indicates that other factors produced by
stromal cells contribute to the induction of GJIC.
Several other investigators have done studies in vitro and in vivo attempting to resolve the
role of PGE2 in tumorigenesis. Studies done with human colorectal tumor tissue have
documented an increase in cyclooxygenase 2 (COX-2) expression [Sano et al., 1995], and
suggested that increased PGE2 production is a factor contributing to the induction of
colorectal cancer. Consistent with this, studies using transgenic mice that overexpress the
human COX-2 gene in their mammary glands showed tumorigenesis and metastasis in a
tissue-specific manner [Lui et al., 2001]. However, increased production of PGE2 was not
sufficient for mammary cancer development; this effect of increased PGE2 only occurred in
the mice after three to four rounds of weaning and pregnancy. Other investigators have
shown that homologous disruption of the genes coding for COX-1 or -2 expression reduced
polyp formation in Min/+ mice by approximately 80% [Chulada et al., 2000]. These
investigators suggested that other factors are required in addition to PGE2 for
carcinogenesis, and that PGE2 is involved with malignant progression. Our results indicate
that a sufficient and localized concentration of PGE2 may block GJIC between normal
epithelial cells (Figure 2) at a concentration of 1 μM. It is conceivable that this
concentration could be attained by inflammation associated with colon carcinoma in situ due
to the release of PGE2 by macrophages responding to intestinal microorganism invasion.
Consequently, suboptimal concentrations of PGE2, e.g. 1 ρM, may not be sufficient to
maintain epithelial cell differentiation and sustain GJIC; the absence of normal epithelial
differentiation and loss of GJIC may contribute to carcinogenesis. Conversely, the presence
of excessive concentrations of PGE2, e.g., 1 μM (Figure 2), may act to inhibit GJIC, which
would also result in carcinogenesis. Measurements done with stromal cell conditioned media
using an ELISA kit showed the PGE2 concentration to be in the picomolar range, and
maximal GJIC was observed when a similar concentration was applied to normal epithelial
cells in vitro (Figure 2).
Besides its effect on normal endometrial epithelial cells, our results also show that PGE2 can
cause GJIC to be re-established in the three transformed endometrial epithelial cells lines
examined. The concentration of PGE2 required for reestablishing GJIC varied for the three
cell lines. It required a 100-fold greater concentration of PGE2 to re-establish GJIC in the
FEEC cells as compared to HEC-1A and RL-95-2 cells. The RL-95-2 cells showed a greater
response than the HEC-1A cells in terms of the number of cells induced to communicate at
the same PGE2 concentrations. HEC-1A cells showed a broader concentration/response
effect than FEEC or RL-95-2 cells, but also show a reduced number of cells that re-establish
GJIC.
Previous observations and those that we report here suggest features of the mechanism by
which GJIC is controlled between endometrial epithelial cells by factors secreted by stromal
cells. Endometrial stromal cells produce PGE2 and PGF2α under physiological conditions,
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and the amount of PGE2 produced is much greater than PGF2α [Gal et al., 1982]. Other
studies have shown that the enzymes for metabolism of prostaglandins are almost
exclusively located in the endometrial epithelial cells and not in the stromal cells [Casey et
al., 1980]. Presumably, stromal cells synthesize and secrete PGE2 into the extracellular
milieu and it then diffuses into the epithelial cells where it is metabolized and induces GJIC
and a number of other cellular functions. This stromal cell induction of GJIC in epithelial
cells is essential to the normal functioning of the epithelium. It is thought that normal GJIC
function might suppress progression of carcinogenesis whereas the loss of GJIC between the
epithelial cells appears to be a feature of developing malignancies. Consistent with this
conjecture is the previous observation that showed normalization of growth control in
transformed cells by transfections that increased the amount of connexin proteins and
enhanced GJIC [Mehta et al., 1991; Rose et al., 1993].
Other studies done with PGE2 have sought to understand the role of PGE2 regarding labor
induction [Adamo, et al., 2001] in a murine model and expression of connexin 43,
cyclooxygenases, and Gsα proteins in the human uterus during pregnancy and labor using
myometrial tissue [Cheng et al., 2001]. The studies described in this report only involve
interactions between uterine stromal and epithelial cells; myometrial tissue was discarded
during tissue processing to isolate primary stromal and epithelial cells. Additionally, studies
done with osteocyte-like MLO-4 cells have documented an increase in Cx 43 expression and
a small but significant increase in GJIC between these cells occurs in the presence of PGE2.
This effect was inhibited by treatment with indomethecin and inducible by the stimulatory
effect of fluid flow, which causes mechanical strain to the cells [Cook et al., 2000].
However, other studies relating Cx 43 expression in oral-derived human osteoblasts with
PGE2 exposure showed no change in Cx 43 expression [Sparey et al., 1999]. In addition,
these studies documented that the levels of Cx 43 expression varied significantly from one
patient to another and also from which oral bone source the cells were isolated. Overall, our
data and the studies of other investigators using different organ systems seem to indicate that
connexin expression, GJIC, and the effects of PGE2, if any, appear to be tissue specific.
Conclusions
Endometrial stromal cells use PGE2 as a paracrine factor to facilitate differentiation (as
exemplified by GJIC function) and to inhibit cell proliferation in endometrial epithelial cells.
The evolution of endometrial cancer is characterized by a loss of endometrial stroma from
between endometrial epithelial glands. We have shown previously that epithelial
endometrial cancer cells secrete products that inhibit endometrial stromal and normal
epithelial cell growth (Albright and Kaufman, 1995; Albright et al., 1995) and that stromal
cells in the absence of hormonal stimulation secrete paracrine products that inhibit
endometrial epithelial cell growth (Watson et al., 1995). It is likely that paracrine factors
secreted by malignant endometrial epithelial cells cause the observed reduction in the ratio
of stromal to epithelial cells seen in endometrial cancer. Consequently the differentiating
effects and reduction of cell proliferation that stromal cells normally produce in epithelial
cells is lost or greatly reduced during the evolution of endometrial cancers. Because the
endometrial epithelial cells in evolving cancers are not constrained by stromal cell paracrine
factors because the stromal cells are decreased in number or are absent, cancer development
would not require the malignant cells to develop abnormal signaling and regulatory
pathways to nullify the inhibitory effects of the stromal cells. Conceivably, endometrial
cancer cells retain their responsiveness to stromal-derived paracrine factors that affect GJIC,
cell proliferation and other cell functions. Our studies test this concept. While malignant
endometrial epithelial cells lose responsiveness to stromal cell regulation by PGE2 as a
consequence of transformation, the loss of responsiveness to PGE2 is not complete because
a 100-fold or greater increase in PGE2 can overcome this deficiency. This is significant
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because it suggests a possible new therapeutic approach for treatment of incipient or overt
endometrial cancer. Perhaps, prostaglandin-like compounds or compounds that cause
increased PGE2 production in the stromal cells could be of benefit in treatment of
endometrial carcinomas or might suppress progression of premalignant lesions of the
endometrium. Other approaches to cancer therapy via effects on gap junctions and GJIC
have been discussed recently (Kandouz and Batist, 2010).
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• Endometrial epithelial and stromal cells in co-culture reproduce tissue functions
in vivo
• Stromal cells in co-culture activate GJIC in normal endometrial epithelial cells
• Conditioned medium can replace stromal cells in co-cultures for activating GJIC
• Stromal cell conditioned medium does not restore GJIC in epithelial cancer cells
• Prostaglandin E2 in medium induced GJIC activity in normal epithelial cells
• Prostaglandin E2 restored some GJIC activity in epithelial cancer cells
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Lucifer yellow dye coupling assay of normal epithelial cells cultured alone, cultured with
medium conditioned, and co-cultured with stromal cells. The black asterisk marks the donor
cell that was injected with Lucifer yellow. 1A. Differential interference contrast (DIC) photo
of normal epithelial cellsa. 1B. Epifluorescence photo of cells shown in 1A five minutes
after microinjection with Lucifer yellow. 1C. DIC photo of normal epithelial cells cultured
with medium conditioned by stromal cellsa. 1D. Epifluorescence photo of cells shown in 1C
five minutes after microinjection with Lucifer yellow. 1E. DIC photo of normal epithelial
cells co-cultured with stromal cellsa. 1F. Epifluorescence photo of cells shown in 1E five
minutes after microinjection with Lucifer yellow. aThese photos were published previously
[Schlemmer and Kaufman, 2000].
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The effect of the concentration of PGE2 on GJIC between normal endometrial epithelial
cells. The percentage of epithelial cells showing GJIC (using epithelial cells alone as 100%)
is shown by the height of the bar graphs under the experimental condition is shown in
parentheses above the asterisks. The statistical probability (p) is shown by the number of
asterisks above each standard deviation upper bound, and are expressed as: * p <0.05; ** p
<0.01; and *** p < 0.001. The number of individual experiments (n) for each condition is
shown in parentheses above the asterisks.
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Lucifer yellow microinjection of FEEC, HEC-1A, and RL-95-2 transformed epithelial cells
alone and with the concentration of PGE2 that produced the maximum amount of GJIC. The
black asterisk marks the dye donor cell. The photos were taken five minutes after
microinjection with Lucifer yellow. 3A. Epifluorescence photo of FEEC cells alone. 3B.
Epifluorescent photo of FEEC cells with 10 μM PGE2. 3C. Epifluorescence photo of
HEC-1A cells alone. 3D. Epifluorescent photo of HEC-1A cells with 100 nM PGE2. 3E.
Epifluorescence photo of RL-95-2 cells alone a.3F. Epifluorescent photo of RL-95-2 cells
with 100 nM PGE2a. aThese photos were published previously [Schlemmer and Kaufman,
2000].
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Concentration/response of PGE2 on GJIC between transformed epithelial cells. The
percentage of transformed epithelial cells showing GJIC (using normal epithelial cells alone
as 100%) is shown by the height of the bar graphs and the PGE2 concentrations below each
set of bars. The results from the FEEC cells are shown as white bars, HEC-1A as gray bars,
and RL-95-2 as black bars. The standard error of the mean is shown by the T-shaped
symbols on top of each bar. The statistical probability (p) is shown by the number of
asterisks above each standard deviation upper bound, and are expressed as: * p <0.05; ** p
<0.01; and *** p < 0.001. The number of individual experiments (n) for each condition is
shown in parentheses above the asterisks.
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TABLE 1
Epithelial Cells Cultured Average Number of Cells Showing GJIC (± SD) n Pa
Alone 1.0 (1.0) 24 0.0025b,e
With Stromal Cells Present 3.2 (2.2) 25 0.00044c,e
With Stromal-Cell-Conditioned Medium 2.5 (1.9) 6 0.0094d
a
Statistical significance determined by Student’s t test
b
Epithelial cells cultured alone vs. malignant epithelial cells cultured alone
c
Epithelial cells cultured alone vs. epithelial cells co-cultured with stromal cells
d
Epithelial cells cultured with stromal-cell-conditioned medium vs. epithelial cells cultured without stromal cell conditioned medium
e
These data were published previously [Schlemmer and Kaufman, 2000].
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